Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
Open Access
- 11 April 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 41 (6), 975-984
- https://doi.org/10.1007/s00134-015-3751-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hospital Deaths in Patients With Sepsis From 2 Independent CohortsPublished by American Medical Association (AMA) ,2014
- Postoperative Polymyxin B Hemoperfusion and Mortality in Patients With Abdominal Septic ShockCritical Care Medicine, 2014
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)Therapeutic Apheresis and Dialysis, 2003
- Continuous Hemodiafiltration with Polymyxin‐B Immobilized Fiber Is Effective in Patients with Sepsis Syndrome and Acute Renal FailureTherapeutic Apheresis, 2002
- Newly Developed Immobilized Polymyxin B Fibers Improve the Survival of Patients with SepsisBlood Purification, 2001
- Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulinInflammation Research, 1999
- Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits.Journal of Applied Physiology, 1997
- Prognosis and Treatment of PeritonitisArchives of Surgery, 1996
- Treatment of Septic Shock with Human Monoclonal Antibody HA-1AAnnals of Internal Medicine, 1994